The global endotracheal tube market size is calculated at USD 2.45 billion in 2025 and is predicted to surpass around USD 4.05 billion by 2034, accelerating at a CAGR of 5.68% from 2025 to 2034. The North America endotracheal tube market size surpassed USD 860 million in 2024 and is expanding at a CAGR of 5.72% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Endotracheal Tube Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Endotracheal Tube Market Revenue and Volume Forecast, by Product Type
8.1.1. Regular Endotracheal Tube
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Reinforced Endotracheal Tube
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Preformed Endotracheal Tube
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Double-Lumen Endotracheal Tube
8.1.4.1. Market Revenue and Volume Forecast
9.1. Endotracheal Tube Market Revenue and Volume Forecast, by Route Type
9.1.1. Orotracheal
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Nasotracheal
9.1.2.1. Market Revenue and Volume Forecast
10.1. Endotracheal Tube Market Revenue and Volume Forecast, by Application
10.1.1. Emergency Treatment
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Therapy
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Others
10.1.3.1. Market Revenue and Volume Forecast
11.1. Endotracheal Tube Market Revenue and Volume Forecast, by End Users
11.1.1. Clinics
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Hospitals
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Ambulatory Surgical Centers
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Others
11.1.4.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Product Type
12.1.2. Market Revenue and Volume Forecast, by Route Type
12.1.3. Market Revenue and Volume Forecast, by Application
12.1.4. Market Revenue and Volume Forecast, by End Users
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Product Type
12.1.5.2. Market Revenue and Volume Forecast, by Route Type
12.1.5.3. Market Revenue and Volume Forecast, by Application
12.1.5.4. Market Revenue and Volume Forecast, by End Users
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Product Type
12.1.6.2. Market Revenue and Volume Forecast, by Route Type
12.1.6.3. Market Revenue and Volume Forecast, by Application
12.1.6.4. Market Revenue and Volume Forecast, by End Users
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Product Type
12.2.2. Market Revenue and Volume Forecast, by Route Type
12.2.3. Market Revenue and Volume Forecast, by Application
12.2.4. Market Revenue and Volume Forecast, by End Users
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Product Type
12.2.5.2. Market Revenue and Volume Forecast, by Route Type
12.2.5.3. Market Revenue and Volume Forecast, by Application
12.2.5.4. Market Revenue and Volume Forecast, by End Users
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Product Type
12.2.6.2. Market Revenue and Volume Forecast, by Route Type
12.2.6.3. Market Revenue and Volume Forecast, by Application
12.2.6.4. Market Revenue and Volume Forecast, by End Users
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Product Type
12.2.7.2. Market Revenue and Volume Forecast, by Route Type
12.2.7.3. Market Revenue and Volume Forecast, by Application
12.2.7.4. Market Revenue and Volume Forecast, by End Users
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Product Type
12.2.8.2. Market Revenue and Volume Forecast, by Route Type
12.2.8.3. Market Revenue and Volume Forecast, by Application
12.2.8.4. Market Revenue and Volume Forecast, by End Users
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Product Type
12.3.2. Market Revenue and Volume Forecast, by Route Type
12.3.3. Market Revenue and Volume Forecast, by Application
12.3.4. Market Revenue and Volume Forecast, by End Users
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Product Type
12.3.5.2. Market Revenue and Volume Forecast, by Route Type
12.3.5.3. Market Revenue and Volume Forecast, by Application
12.3.5.4. Market Revenue and Volume Forecast, by End Users
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Product Type
12.3.6.2. Market Revenue and Volume Forecast, by Route Type
12.3.6.3. Market Revenue and Volume Forecast, by Application
12.3.6.4. Market Revenue and Volume Forecast, by End Users
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Product Type
12.3.7.2. Market Revenue and Volume Forecast, by Route Type
12.3.7.3. Market Revenue and Volume Forecast, by Application
12.3.7.4. Market Revenue and Volume Forecast, by End Users
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Product Type
12.3.8.2. Market Revenue and Volume Forecast, by Route Type
12.3.8.3. Market Revenue and Volume Forecast, by Application
12.3.8.4. Market Revenue and Volume Forecast, by End Users
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Product Type
12.4.2. Market Revenue and Volume Forecast, by Route Type
12.4.3. Market Revenue and Volume Forecast, by Application
12.4.4. Market Revenue and Volume Forecast, by End Users
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Product Type
12.4.5.2. Market Revenue and Volume Forecast, by Route Type
12.4.5.3. Market Revenue and Volume Forecast, by Application
12.4.5.4. Market Revenue and Volume Forecast, by End Users
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Product Type
12.4.6.2. Market Revenue and Volume Forecast, by Route Type
12.4.6.3. Market Revenue and Volume Forecast, by Application
12.4.6.4. Market Revenue and Volume Forecast, by End Users
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Product Type
12.4.7.2. Market Revenue and Volume Forecast, by Route Type
12.4.7.3. Market Revenue and Volume Forecast, by Application
12.4.7.4. Market Revenue and Volume Forecast, by End Users
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Product Type
12.4.8.2. Market Revenue and Volume Forecast, by Route Type
12.4.8.3. Market Revenue and Volume Forecast, by Application
12.4.8.4. Market Revenue and Volume Forecast, by End Users
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Product Type
12.5.2. Market Revenue and Volume Forecast, by Route Type
12.5.3. Market Revenue and Volume Forecast, by Application
12.5.4. Market Revenue and Volume Forecast, by End Users
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Product Type
12.5.5.2. Market Revenue and Volume Forecast, by Route Type
12.5.5.3. Market Revenue and Volume Forecast, by Application
12.5.5.4. Market Revenue and Volume Forecast, by End Users
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Product Type
12.5.6.2. Market Revenue and Volume Forecast, by Route Type
12.5.6.3. Market Revenue and Volume Forecast, by Application
12.5.6.4. Market Revenue and Volume Forecast, by End Users
13.1. Medtronic plc
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Teleflex Incorporated
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Smith’s Medical (A Division of Smiths Group plc)
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. C. R. Bard, Inc. (Becton, Dickinson and Company)
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Intersurgical Ltd.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Medline Industries, Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Parker Medical
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Vyaire Medical, Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. BOMImed
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Armstrong Medical
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample